“a strong trend”

We found a significantly higher rate of immediate progression in rectal NEC with ARID1A deletions (56 vs 33%, OR 6.43, 95%CI 1.05–39.33, p = 0.044) and a strong trend towards inferior RR (OR 0.19, 95%CI 0.03–1.02, p = 0.052).

In addition, PFI was 32.7 months (95% CI 13.8-NA) in the all genetic mutation group, and 15.9 months (95% CI 8.3-34.1) in the HRP group, showing a strong trend toward statistical difference (p= 0.052).

In addition, we observed a strong trend for a higher occurrence of nausea (52.9% vs. 27.9%; P = .052) and obstipation (5.9% vs. 0.0%; P = .057) in patients with prior antibiotic use.

Additionally, the results of a meta-analysis indicated a strong trend towards increased live birth rates following VR prior to ICSI (odd ratio=2.208, p=0.052) [ 43 ].

Although a strong trend was noted, it was not statistically significant ( p = 0.0527).

In female rats, PWTs in the vehicle group were significantly different from HBL on Day 11 ( p = 0.0313), Day 16 ( p < 0.0001) and Day 19 ( p = 0.0028), with a strong trend towards significance on Day 15 ( p = 0.0529).

We observed a strong trend toward a reduction of the duration of lever-press-evoked inhibitions by deconvolution (KS = 0.22, P = 0.053).

We quantified the number of cyclic genes in each region within each community, and found a strong trend toward a significant difference between groups (One-way ANOVA, p = 0.053; Figure 3 E).

At the dose of 5 mg/kg, NPO showed a strong trend toward protection, but it did not reach statistical significance (36.2 ± 4.2%, p = 0.053).

For this sub-sample ( n = 92), the rate of participants endorsing recurrent NAMs was 68.5 % and all the significant differences between those who did and did not endorsed recurrent NAMs, correlations, and regressions were maintained, except the comparison of DASS-21 scores for female participants ( n = 74) who did and did not endorse recurrent NAMs was reduced to a strong trend, U = 366.5 , p = .053, d = 0.46.

Although the initial 4-way ANOVA failed to yield a significant interaction [F(1,42) = 0.057, P = 0.812, eta = 0.001], the data revealed a strong trend for a Day × Initial Exposure interaction [F(1,42) = 3.966, P = 0.053, eta = 0.086].

In animals immunized with V2-TTB NPs carrying V2, the otherwise deleterious effects of the nanoparticle platform inhibiting immune responses and favoring infection were likely counteracted by the increased mucosal and systemic immune responses to V2 (such as increased antibody avidity, V2-specific ADCC, and mucosal B cells secreting IgG and IgA against envelope protein) induced by the V2-TTB NP prime-boost, thereby rescuing vaccine efficacy with a strong trend emerging toward significant protection ( p = 0.053).

1 c, multiple comparisons test: *** p = 0.0009), and a strong trend for increase between Braak III–IV and Braak VI (Fig. 1 c, multiple comparisons test: p = 0.053).

For social-emotional skills, a strong trend ( F (4, 30) = 2.63, p = 0.053, η2 p = 0.25, model fit BIC = 3032.24) indicated pre-test differences and post-hoc tests indicated that the drop out group ( M = 12.24, SE = 0.46) reported significantly lower social-emotional skills than the full program ( M = 13.78, SE = 0.25, p = 0.006, 95% C.I. = [−2.60, −0.48]) and the control group ( M = 13.68, SE = 0.19 , p = 0.006, 95% C.I. = [−2.45, −0.44]).

3 b), effects of diet group was significant, with higher values for fish fed control than those fed synbiotic diet, and a strong trend ( p = 0.053) towards a decreasing effect of time.

Young mice—RA-treated males were characterised by a strong trend towards significantly higher glycaemia (F(4,76) = 2.451; p = 0.0532).

These differences were not statistically significant, but there is a strong trend ( p = 0.0537) (Figure 3B ).

However, treatment with BM-LCNs induced a strong trend towards a reduction in M1 macrophage infiltration (p = 0.0539), although this did not result in a significant reduction (Supplementary Figure 1E, F).

The main outcome was driven by hospitalizations for heart failure, and with adjustment for eGFR and NT-proBNP, a strong trend ( P = .054) was seen towards lower risk for heart failure hospitalizations.

While there was a strong trend toward a prolonged intubation ( p = 0.054), a prolonged ICU stay was significantly more likely in the higher initial AP drop cohort (31.9 vs. 48.0%; p = 0.004).

Furthermore, ND showed a strong trend ( P = 0.054; Fig. 1C ) for significantly elevated protein synthesis rates in animals sacrificed at an older age.

When adjusted for CCS and age at V1, years between first and final CCS measurement, years of education and medication, there was a strong trend for a difference between adropin tertiles ( F 2,446 = 2.931, P = 0.054; estimated marginal mean ± SE of ∆CCS for 1st, 2nd, and 3rd adropin tertiles, − 0.298 ± 0.059, − 0.253 ± 0.057, and − 0.104 ± 0.059, P = 0.065 between 1st and 3rd adropin tertiles).

However, pyruvate and butyrate showed a strong trend for reduced SRC (ANOVA p = 0.054, 0.082 respectively), less so for succinate (0.134) as the data were variable.

There was a strong trend for genus [ F (2, 37.99) = 3.163, P = 0.054], with orangutans spinning for more revolutions per bout than gorillas [ t = 2.312, P = 0.026; Fig. 1 E].

Although no individual DRN subregion showed a significant effect of social treatment, there was a strong trend in the DRD (Least Significant Difference post hoc test, p = 0.055), but not for other regions ( p > 0.2 for the DRL, DRV, and PDR).